Patrick T. Flaherty

866 total citations
44 papers, 589 citations indexed

About

Patrick T. Flaherty is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Patrick T. Flaherty has authored 44 papers receiving a total of 589 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 10 papers in Organic Chemistry and 8 papers in Oncology. Recurrent topics in Patrick T. Flaherty's work include Melanoma and MAPK Pathways (11 papers), Synthesis and biological activity (4 papers) and Cancer Cells and Metastasis (4 papers). Patrick T. Flaherty is often cited by papers focused on Melanoma and MAPK Pathways (11 papers), Synthesis and biological activity (4 papers) and Cancer Cells and Metastasis (4 papers). Patrick T. Flaherty collaborates with scholars based in United States, Belgium and France. Patrick T. Flaherty's co-authors include Jane E. Cavanaugh, Matthew E. Burow, Robert P. St.Onge, Adam P. Arkin, Guri Giaever, Prashi Jain, Corey Nislow, Michael Proctor, Michael I. Jordan and Van T. Hoang and has published in prestigious journals such as Chemical Communications, Journal of Medicinal Chemistry and The Journal of Organic Chemistry.

In The Last Decade

Patrick T. Flaherty

40 papers receiving 584 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Patrick T. Flaherty United States 15 364 139 87 56 43 44 589
Ming Guo China 8 353 1.0× 132 0.9× 134 1.5× 44 0.8× 21 0.5× 14 540
Lubna H. Tahtamouni Jordan 14 244 0.7× 177 1.3× 97 1.1× 45 0.8× 53 1.2× 64 714
Sevil Zencir Türkiye 13 355 1.0× 130 0.9× 89 1.0× 37 0.7× 21 0.5× 32 579
Agnese Chiara Pippione Italy 15 296 0.8× 108 0.8× 31 0.4× 65 1.2× 54 1.3× 22 567
V. Cavett United States 17 624 1.7× 181 1.3× 94 1.1× 51 0.9× 15 0.3× 23 990
Georgios Konstantinidis Serbia 14 251 0.7× 73 0.5× 106 1.2× 71 1.3× 56 1.3× 50 663
Kenneth D. Bromberg United States 14 746 2.0× 80 0.6× 163 1.9× 67 1.2× 25 0.6× 17 926
Esther Marco Spain 15 342 0.9× 225 1.6× 117 1.3× 86 1.5× 80 1.9× 28 789
Kwan‐Young Jung South Korea 18 562 1.5× 364 2.6× 112 1.3× 28 0.5× 60 1.4× 52 975
Charlotte Revill United Kingdom 9 319 0.9× 63 0.5× 75 0.9× 24 0.4× 67 1.6× 12 555

Countries citing papers authored by Patrick T. Flaherty

Since Specialization
Citations

This map shows the geographic impact of Patrick T. Flaherty's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick T. Flaherty with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick T. Flaherty more than expected).

Fields of papers citing papers by Patrick T. Flaherty

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick T. Flaherty. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick T. Flaherty. The network helps show where Patrick T. Flaherty may publish in the future.

Co-authorship network of co-authors of Patrick T. Flaherty

This figure shows the co-authorship network connecting the top 25 collaborators of Patrick T. Flaherty. A scholar is included among the top collaborators of Patrick T. Flaherty based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrick T. Flaherty. Patrick T. Flaherty is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cook, Thomas D., et al.. (2024). Cost-Aware Generalized α-Investing for Multiple Hypothesis Testing. 155–174.
2.
Flaherty, Patrick T., et al.. (2022). Crystal structure of 4-bromo-N-(propylcarbamoyl)benzenesulfonamide. Acta Crystallographica Section E Crystallographic Communications. 78(5). 485–489. 1 indexed citations
3.
Wright, Thomas D., Margarite D. Matossian, Deniz A. Uçar, et al.. (2021). Diverse and converging roles of ERK1/2 and ERK5 pathways on mesenchymal to epithelial transition in breast cancer. Translational Oncology. 14(6). 101046–101046. 8 indexed citations
4.
Gupta, Mohit, et al.. (2021). Crystal structure of tert-butyl 4-[4-(4-fluorophenyl)-2-methylbut-3-yn-2-yl]piperazine-1-carboxylate. Acta Crystallographica Section E Crystallographic Communications. 77(4). 360–365. 1 indexed citations
5.
Zhang, Jing, et al.. (2020). Management Students' Perceptions of Online Teaching Quality.. 14(2). 33–52. 3 indexed citations
6.
Wright, Thomas D., et al.. (2019). Abstract B078: Inhibition of the MAPK pathways enhances the sensitivity of triple negative breast cancer cells to chemotherapeutic drugs. Molecular Cancer Therapeutics. 18(12_Supplement). B078–B078.
7.
Rodriguez‐Araujo, Gerardo, Mehmet Çilingiroğlu, David M. Mego, et al.. (2018). Same versus next day discharge after elective transradial PCI: The RAdial SAme Day DischArge after PCI trial. (The RASADDA-PCI trial). Cardiovascular revascularization medicine. 19(6). 7–11. 11 indexed citations
8.
Çilingiroğlu, Mehmet, David M. Mego, Ian Cawich, et al.. (2017). LBT-7 Feasibility And Clinical Importance Of Same Versus Next Day Discharge After Elective Transradial Percutaneous Coronary Intervention, The Rasadda-pci Trial. JACC: Cardiovascular Interventions. 10(3). S3–S3. 1 indexed citations
9.
Hoang, Van T., et al.. (2017). Oncogenic signaling of MEK5-ERK5. Cancer Letters. 392. 51–59. 69 indexed citations
10.
Gleixner, Amanda M., Sara Sannino, Tarun N. Bhatia, et al.. (2017). N-Acetyl-l-Cysteine Protects Astrocytes against Proteotoxicity without Recourse to Glutathione. Molecular Pharmacology. 92(5). 564–575. 31 indexed citations
11.
Bisht, Savita, Jens Nolting, Ute Schütte, et al.. (2015). Cyclin-Dependent Kinase 5 (CDK5) Controls Melanoma Cell Motility, Invasiveness, and Metastatic Spread—Identification of a Promising Novel therapeutic target. Translational Oncology. 8(4). 295–307. 27 indexed citations
12.
Weaver, Sean, et al.. (2015). Robotic Assistive Device for Phlebotomy. 5 indexed citations
13.
Acevedo, Orlando, et al.. (2012). Identification of HIV Inhibitors Guided by Free Energy Perturbation Calculations. Current Pharmaceutical Design. 18(9). 1199–1216. 16 indexed citations
14.
Jain, Prashi, Patrick T. Flaherty, Ishveen Chopra, et al.. (2010). Design, synthesis, and testing of an 6-O-linked series of benzimidazole based inhibitors of CDK5/p25. Bioorganic & Medicinal Chemistry. 19(1). 359–373. 19 indexed citations
15.
Flaherty, Patrick T., et al.. (2010). Identification of benzimidazole-based inhibitors of the mitogen activated kinase-5 signaling pathway. Bioorganic & Medicinal Chemistry Letters. 20(9). 2892–2896. 13 indexed citations
16.
Lee, William, Robert P. St.Onge, Michael Proctor, et al.. (2005). Genome-Wide Requirements for Resistance to Functionally Distinct DNA-Damaging Agents. PLoS Genetics. 1(2). e24–e24. 130 indexed citations
17.
Flaherty, Patrick T., et al.. (1998). Acute hospital admission systems: problems experienced by general practitioners.. PubMed. 91(1). 19–20.
18.
Flaherty, Patrick T., et al.. (1996). Synthesis and Evaluation of N-(Phenylacetyl)trifluoromethanesulfonamides as Anticonvulsant Agents. Journal of Medicinal Chemistry. 39(7). 1509–1513. 34 indexed citations
19.
Cannon, Joseph G., et al.. (1995). A-Ring Ortho-Disubstituted Aporphine Derivatives as Potential Agonists or Antagonists at Serotonergic 5-HT1A Receptors. Journal of Medicinal Chemistry. 38(11). 1841–1845. 14 indexed citations
20.
Flaherty, Patrick T., et al.. (1989). Use of laser to extract unwanted pacemaker leads.. PubMed. 16(3). 163–8. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ming Guo Breakdown of academic impact, for papers by Lubna H. Tahtamouni Breakdown of academic impact, for papers by Sevil Zencir Breakdown of academic impact, for papers by Agnese Chiara Pippione Breakdown of academic impact, for papers by V. Cavett Breakdown of academic impact, for papers by Georgios Konstantinidis Breakdown of academic impact, for papers by Kenneth D. Bromberg Breakdown of academic impact, for papers by Esther Marco Breakdown of academic impact, for papers by Kwan‐Young Jung Breakdown of academic impact, for papers by Charlotte Revill
Rankless by CCL
2026